KIP Infrastructure
2.12.2 - ci-build

KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions

CodeSystem: WHO ATC

Official URL: https://kip.rkkp.dk/fhir/CodeSystem/ATC Version: 2.12.2
Active as of 2022-06-14 Computable Name: ATC
Other Identifiers: urn:oid:2.16.840.1.113883.6.73

WHO ATC code system. Link: http://www.whocc.no/atc

This Code system is referenced in the content logical definition of the following value sets:

This case-sensitive code system https://kip.rkkp.dk/fhir/CodeSystem/ATC provides a fragment that includes following codes in an undefined hierarchy:

LvlCodeDisplayDefinition
1 B01A ANTITHROMBOTIC AGENTS B01A - ANTITHROMBOTIC AGENTS
2   B01AA03 warfarin B01AA03 - warfarin
2   B01AB01 heparin B01AB01 - heparin
2   B01AB04 dalteparin B01AB04 - dalteparin
2   B01AB05 enoxaparin B01AB05 - enoxaparin
2   B01AB10 tinzaparin B01AB10 - tinzaparin
2   B01AC06 acetylsalicylic acid B01AC06 - acetylsalicylic acid
2   B01AE07 dabigatran etexilate B01AE07 - dabigatran etexilate
2   B01AF01 rivaroxaban B01AF01 - rivaroxaban
2   B01AF02 apixaban B01AF02 - apixaban
2   B01AX05 fondaparinux B01AX05 - fondaparinux
1 B02AA02 tranexamic acid B02AA02 - Tranexamic acid
1 B03XA01 erythropoietin B03XA01 - erythropoietin
1 C10AA HMG CoA reductase inhibitors C10AA - HMG CoA reductase inhibitors
1 H02 CORTICOSTEROIDS FOR SYSTEMIC USE H02 - CORTICOSTEROIDS FOR SYSTEMIC USE
1 J01CF01 dicloxacillin J01CF01 - dicloxacillin
1 J01CF02 cloxacillin J01CF02 - cloxacillin
1 J01CF03 meticillin J01CF03 - meticillin
1 J01CF05 flucloxacillin J01CF05 - flucloxacillin
1 J01DB01 cefalexin J01DB01 - cefalexin
1 J01DB03 cefalotin J01DB03 - cefalotin
1 J01DC02 cefuroxime J01DC02 - cefuroxime
1 J01FA01 erythromycin J01FA01 - erythromycin
1 J01GB03 gentamicin J01GB03 - gentamicin
1 J01XA01 vancomycin J01XA01 - vancomycin
1 L01AA01 cyclophosphamide L01AA01 - cyclophosphamide
1 L01AA02 chlorambucil L01AA02 - chlorambucil
1 L01AA03 melphalan L01AA03 - melphalan
1 L01AA06 ifosfamide L01AA06 - ifosfamide
1 L01AA09 bendamustine L01AA09 - bendamustine
1 L01AB01 busulfan L01AB01 - busulfan
1 L01AC01 thiotepa L01AC01 thiotepa
1 L01AD01 carmustine L01AD01 - carmustine
1 L01AX03 temozolomide L01AX03 - temozolomide
1 L01AX04 dacarbazine L01AX04 - dacarbazine
1 L01BB05 fludarabine L01BB05 - fludarabine
1 L01BC02 fluorouracil L01BC02 - Fluorouracil (5-FU)
1 L01BC05 gemcitabine L01BC02 - Gemcitabine
1 L01BC06 capecitabine L01BC06 - Capecitabine
1 L01BC07 azacitidine L01BC07 - azacitidine
1 L01CA02 vincristine L01CA02 - vincristine
1 L01CA04 vinorelbine L01CA04 - Vinorelbine
1 L01CB01 etoposide L01CB01 - etoposide
1 L01CD01 paclitaxel L01CD01 - Paclitaxel
1 L01CD02 docetaxel L01CD02 - Docetaxel
1 L01CE02 irinotecan L01CE02 - Irinotecan
1 L01DB01 doxorubicin L01DB01 - Doxorubicin
1 L01DB03 epirubicin L01DB03 - Epirubicin
1 L01DB07 mitoxantrone L01DB07 - mitoxantrone
1 L01DB11 pixantrone L01DB11 - pixantrone
1 L01DC01 bleomycin L01DC01 - bleomycin
1 L01EA BCR-ABL tyrosine kinase inhibitors
2   L01EA01 imatinib L01EA01 - imatinib
2   L01EA02 dasatinib L01EA02 - dasatinib
2   L01EA03 nilotinib L01EA03 - nilotinib
2   L01EA04 bosutinib L01EA04 - bosutinib
2   L01EA05 ponatinib L01EA05 - ponatinib
2   L01EA06 Asciminib L01EA06 - Asciminib
1 L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
1 L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
1 L01EJ Janus-associated kinase (JAK) inhibitors Janus associerede kinase (JAK) hæmmere
2   L01EJ01 ruxolitinib L01EJ01 - ruxolitinib
1 L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
1 L01EL01 ibrutinib L01EL01 - ibrutinib
1 L01EL02 acalabrutinib L01EL02 - acalabrutinib
1 L01EM01 idelalisib L01EM01 - idelalisib
1 L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
1 L01FA01 rituximab L01FA01 - rituximab
1 L01FA02 ofatumumab L01FA02 - ofatumumab
1 L01FA03 obinutuzumab L01FA03 - obinutuzumab
1 L01FC01 daratumumab L01FC01 - daratumumab
1 L01FC02 isatuximab L01FC02 - isatuximab
1 L01FD01 trastuzumab L01FD01 - Trastuzumab
1 L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
2   L01FF01 nivolumab L01FF01 - Nivolumab
2   L01FF02 pembrolizumab L01FF02 - Pembrolizumab
1 L01FG01 bevacizumab L01FG01 - Bevacizumab
1 L01FX05 brentuximab vedotin L01FX05 - brentuximab vedotin
1 L01FX08 elotuzumab L01FX08 - elotuzumab
1 L01FX14 polatuzumab vedotin L01FX14 - polatuzumab vedotin
1 L01XA01 cisplatin L01XA01 - Cisplatin
1 L01XA02 carboplatin L01XA02 - Carboplatin
1 L01XA03 oxaliplatin L01XA03 - Oxaliplatin
1 L01XG01 bortezomib L01XG01 - bortezomib
1 L01XG02 carfilzomib L01XG02 - carfilzomib
1 L01XG03 ixazomib L01XG03 - ixazomib
1 L01XH Histone deacetylase (HDAC) inhibitors L01XH - Histone deacetylase (HDAC) inhibitors
2   L01XH01 vorinostat L01XH01 - vorinostat
2   L01XH03 panobinostat L01XH03 - panobinostat
1 L01XX05 hydroxycarbamide L01XX05 - hydroxycarbamide
1 L01XX35 anagrelide L01XX35 - anagrelide
1 L01XX52 venetoclax L01XX52 - venetoclax
1 L03AB Interferons L03AB - Interferons
1 L04A IMMUNOSUPPRESSANTS L04A - IMMUNOSUPPRESSANTS
2   L04AA Selective immunosuppressants L04AA - Selective immunosuppressants
3     L04AA34 alemtuzumab L04AA34 - alemtuzumab
3     L04AA40 cladribine L04AA40 - cladribine
1 L04AD01 ciclosporin L04AD01 - ciclosporin
1 L04AX02 thalidomide L04AX02 - thalidomide
1 L04AX04 lenalidomide L04AX04 - lenalidomide
1 L04AX06 pomalidomide L04AX06 - pomalidomide
1 M05BA03 pamidronic acid M05BA03 - pamidronic acid
1 M05BA08 zoledronic acid M05BA08 - zoledronic acid
1 M05BX04 denosumab M05BX04 - denosumab
1 S01LA08 bevacizumab S01LA08 - Bevacizumab
1 V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALS V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS
2   V10XA53 tositumomab/iodine (131I) tositumomab V10XA53 - tositumomab/iodine (131I) tositumomab
2   V10XX02 ibritumomab tiuxetan (90Y) V10XX02 - ibritumomab tiuxetan (90Y)